Seres therapeutics to participate in cowen 43rd annual health care conference

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, today announced that eric shaff, president and chief executive officer of seres therapeutics, will participate in a panel discussion at the cowen 43rd annual health care conference on monday, march 6, 2023 at 9:10 a.m. et. an audio webcast of the panel discussion will be available under the “investors and news” section of seres' website.
MCRB Ratings Summary
MCRB Quant Ranking